Editorial: Multiple Sclerosis: Pathogenesis and Therapeutics

Multiple sclerosis (MS) is demyelinating disorder of the central nervous system of autoimmune aetiology.Numerous treatment options are available to patients with MS, however these need to be improved as side effects and long term effectiveness are limited.Herein, we present therapeutic approaches to disease management as well as neuropathic pain management in patients with MS.In addition, new onset of disease has been described to be attributed to certain compounds that induce blood brain barrier disruptions in addition to certain vitamin deficiencies.Since the current treatment of MS remains elusive and are limited, recent advances offer an optimistic outlook.